Kolexia
Dupuis Charlotte Oncologie médicale
Dupuis Charlotte
Oncologie médicale
Hôpital La Timone
Marseille, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Liposarcome Déficit en dihydropyrimidine déshydrogénase Récidive tumorale locale Métastase lymphatique {{person.topmesh10.name}}

Collaborateurs

Voir plus
Deville Jean-Laurent
Deville Jean-Laurent
Hôpital La Timone, Marseille, France
Fichaux-Antonini Marie
Fichaux-Antonini Marie
Hôpital La Timone, Marseille, France
Andriantsoa Maeva
Andriantsoa Maeva
Cabinet libéral, Stains, France
Meurer Marie
Meurer Marie
Hôpital La Timone, Marseille, France

Industries

Voir plus
Grünenthal
1 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2020
GSK
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS.
Clinical cancer drugs   17 mars 2022
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.
Cancer medicine   25 mai 2021
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.
Scientific reports   02 juin 2017
Paravertebral Well-Differentiated Liposarcoma with Low-Grade Osteosarcomatous Component: Case Report with 11-Year Follow-Up, Radiological, Pathological, and Genetic Data, and Literature Review.
Case reports in pathology   09 mars 2017
Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   08 mars 2016
Induction chemotherapy with docetaxel, cisplatin, and 5FU (TPF) in unresectable advanced head and neck squamous cell carcinoma: Retrospective analysis of 300 cases and proposal for a prognostic index.
2012 ASCO Annual Meeting I   20 mai 2012
Phase II study of postperative radiotherapy (RT), cisplatin (Ci), and cetuximab (Ce) in resected bad prognostic head and neck squamous cell carcinoma (HNSCC): Toxicity analysis.
2012 ASCO Annual Meeting I   20 mai 2012
Induction TPF followed by chemoradiation or radiotherapy-cetuximab in nonresectable advanced head and neck squamous cell carcinoma: A retrospective study in 164 patients.
2012 ASCO Annual Meeting I   20 mai 2012
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}